Results 141 to 150 of about 150,839 (152)

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

New England Journal of Medicine, 2003
Robert Hal Scofield, Judith A James, John B Harley   +2 more
exaly  

New insights into the immunopathogenesis of systemic lupus erythematosus

Nature Reviews Rheumatology, 2016
George C Tsokos, Mindy S Lo, Kathleen E Sullivan   +2 more
exaly  

Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

New England Journal of Medicine, 2003
Mary K Crow, Joseph E Schwartz
exaly  

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Lancet, The, 2018
Zhi-wei Lai, Stephen Faraone, Andras Perl   +2 more
exaly  

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Lancet, The, 2018
Ronald F Van Vollenhoven, George C Tsokos, Peter E Lipsky   +2 more
exaly  

Systemic lupus erythematosus and lupus nephritis

Nature Reviews Drug Discovery, 2014
exaly  

Novel paradigms in systemic lupus erythematosus

Lancet, The, 2019
Thomas Dörner, Richard A Furie
exaly  

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

Lancet, The, 1996
Michelle A Petri, Ronenn Roubenoff, Jacob Selhub   +2 more
exaly  

Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies

Nature Reviews Rheumatology, 2019
Joerg Wenzel
exaly  

Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus

Nature Genetics, 2011
Sulaiman M Al-Mayouf, Reem Abdwani, Safiya Albrawi   +2 more
exaly